<SEC-DOCUMENT>0001193125-20-304082.txt : 20201127
<SEC-HEADER>0001193125-20-304082.hdr.sgml : 20201127
<ACCEPTANCE-DATETIME>20201127060852
ACCESSION NUMBER:		0001193125-20-304082
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20201127
FILED AS OF DATE:		20201127
DATE AS OF CHANGE:		20201127

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JD.com, Inc.
		CENTRAL INDEX KEY:			0001549802
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-RETAIL STORES, NEC [5990]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36450
		FILM NUMBER:		201352704

	BUSINESS ADDRESS:	
		STREET 1:		20TH FLOOR, BUILDING A, NO. 18 KECHUANG
		STREET 2:		YIZHUANG BDA
		CITY:			DAXING DISTRICT, BEIJING
		STATE:			F4
		ZIP:			101111
		BUSINESS PHONE:		86-10-5895-5500

	MAIL ADDRESS:	
		STREET 1:		20TH FLOOR, BUILDING A, NO. 18 KECHUANG
		STREET 2:		YIZHUANG BDA
		CITY:			DAXING DISTRICT, BEIJING
		STATE:			F4
		ZIP:			101111

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	360buy Jingdong Inc.
		DATE OF NAME CHANGE:	20120511
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d14983d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>FORM 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF
FOREIGN PRIVATE ISSUER </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE <FONT STYLE="white-space:nowrap">13a-16</FONT> OR
<FONT STYLE="white-space:nowrap">15d-16</FONT> UNDER </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of November 2020 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number: <FONT STYLE="white-space:nowrap">001-36450</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>JD.com, Inc. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>20th&nbsp;Floor, Building A, No.&nbsp;18 Kechuang 11 Street </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Yizhuang Economic and Technological Development Zone </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Daxing District,&nbsp;Beijing 101111 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The People&#146;s Republic of China </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT STYLE="white-space:nowrap">40-F.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form
<FONT STYLE="white-space:nowrap">20-F&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form</FONT> <FONT STYLE="white-space:nowrap">40-F&nbsp;&nbsp;&#9744;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT
STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(1):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT
STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(7):&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit Index </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Announcement &#150; Publication of the Prospectus Issued by JD Health International Inc. and Expected Size of the Global Offering and Offer Price Range</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SIGNATURES </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>JD.COM, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By :</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sandy Ran Xu</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name&nbsp;:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Sandy Ran Xu</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title :</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: November&nbsp;27, 2020 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d14983dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited (the &#147;</I><B><I>Hong Kong Stock Exchange</I></B><I>&#148;) take
no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the
contents of this announcement. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Under our weighted voting rights structure, our share capital comprises Class&nbsp;A ordinary shares and
Class&nbsp;B ordinary shares. Each Class&nbsp;A ordinary share entitles the holder to exercise one vote, and each Class&nbsp;B ordinary share entitles the holder to exercise 20 votes, respectively, on any resolution tabled at our general meetings,
except as may otherwise be required by law or provided for in our Memorandum and Articles of Association. Shareholders and prospective investors should be aware of the potential risks of investing in a company with a weighted voting rights
structure. Our American depositary shares, each representing two of our Class&nbsp;A ordinary shares, are listed on the Nasdaq Global Select Market in the United States under the symbol JD. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This announcement is for information purpose only and does not constitute an invitation or offer to acquire, purchase or subscribe for securities nor is it
calculated to invite any such offer or invitation. In particular, this announcement does not constitute and is not an offer to sell or an invitation or a solicitation of any offer to buy or subscribe for any securities in Hong Kong, the United
States of America or elsewhere. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>JD.com, Inc. has not intended and does not intend to register any securities referred to in this announcement
under the United States Securities Act of 1933, as amended (the &#147;</I><B><I>US Securities Act</I></B><I>&#148;) and such securities may not be offered or sold in the United States of America absent registration under the US Securities Act or an
applicable exemption from the registration requirements under the US Securities Act or any applicable state securities laws of the United States of America. Any public offering of securities in the United States of America will be made by means of a
prospectus or offering memorandum that may be obtained from the issuer or selling security holder and that would contain detailed information regarding the issuer and its management, as well as financial statements. JD.com, Inc. does not intend to
register any part of the offering in the United States of America or to conduct a public offering of securities in the United States of America. </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g14983g38t41.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>JD.com, Inc. </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g14983g40y88.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(A company controlled through weighted voting rights and incorporated in the Cayman Islands with limited
liability) </I></P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Stock Code: 9618) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSED <FONT STYLE="white-space:nowrap">SPIN-OFF</FONT> AND SEPARATE LISTING OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>JD HEALTH INTERNATIONAL INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ON THE MAIN BOARD OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE
STOCK EXCHANGE OF HONG KONG LIMITED </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PUBLICATION OF THE PROSPECTUS ISSUED BY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>JD HEALTH INTERNATIONAL INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPECTED SIZE OF THE
GLOBAL OFFERING AND </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OFFER PRICE RANGE </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">In connection with the Proposed <FONT STYLE="white-space:nowrap">Spin-off</FONT> and the Global Offering, JD Health published
the Prospectus on November&nbsp;26, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">As disclosed in the Prospectus, the total number of the JD Health Shares to
be offered pursuant to the Global Offering will be 381,900,000, representing approximately 12.21% of the total number of the JD Health Shares in issue immediately following the completion of the Global Offering (assuming the Over-allotment Option is
not exercised), and 439,185,000, representing approximately 13.79% of the total number of JD Health Shares in issue immediately following the completion of the Global Offering (assuming the Over-allotment Option is exercised in full). </P></div>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>INTRODUCTION </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reference is made to the announcements of
the Company dated September&nbsp;27, 2020 and November&nbsp;15, 2020 (the &#147;<B>Announcements</B>&#148;) in relation to the Proposed <FONT STYLE="white-space:nowrap">Spin-off.</FONT> Unless otherwise defined, capitalised terms used in this
announcement shall have the same meanings as those defined in the Announcements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PUBLICATION OF THE PROSPECTUS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Proposed <FONT STYLE="white-space:nowrap">Spin-off</FONT> and the Global Offering, JD Health published the Prospectus on
November&nbsp;26, 2020. The Prospectus contains, among other things, (a)&nbsp;details of the number of the JD Health Shares to be offered in the Global Offering, the offer price range, other details of the Global Offering and (b)&nbsp;certain
business and financial information in relation to the JD Health and its subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">JD Health has decided to adopt a fully electronic application
process for the Hong Kong Public Offering, with no printed copies of prospectuses or application forms. A fully electronic application process is consistent with the way in which JD Health&#146;s users and stakeholders engage and interact with each
other and JD Health. As a company which has been highly committed to environmental, social and corporate responsibility matters since its founding, JD Health believes such method will also help mitigate the environmental impact of printing and
minimize the exploitation of natural resources, among others. The Prospectus is available for viewing and downloading from the websites of JD Health at <B><U>https://ir.jdhealth.com</U></B> and the Hong Kong Stock Exchange at <B><U>www.
hkexnews.hk</U></B> from November&nbsp;26, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>EXPECTED SIZE OF THE GLOBAL OFFERING AND OFFER PRICE RANGE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As disclosed in the Prospectus, the total number of the JD Health Shares to be offered pursuant to the Global Offering will be 381,900,000, representing
approximately 12.21% of the total number of the JD Health Shares in issue immediately following the completion of the Global Offering (assuming the Over-allotment Option is not exercised), and 439,185,000, representing approximately 13.79% of the
total number of the JD Health Shares in issue immediately following the completion of the Global Offering (assuming the Over-allotment Option is exercised in full). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The offer price for the JD Health Shares in the Global Offering is expected to be not less than HK$62.80 per
JD Health Share and not more than HK$70.58 per JD Health Share (exclusive of brokerage of 1.0%, SFC transaction levy of 0.0027% and Hong Kong Stock Exchange trading fee of 0.005%). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the basis of the number of the JD Health Shares to be offered pursuant to the Global Offering and the expected offer price range as stated above, if the
Global Offering proceeds (assuming the Over-Allotment Option is not exercised): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the market capitalisation of JD Health will be between approximately HK$196,381&nbsp;million and approximately
HK$220,709&nbsp;million; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company, through its wholly-owned subsidiary, will hold approximately 68.73% of the total issued share
capital of JD Health immediately upon completion of the Global Offering (assuming that the Over-allotment Option is not exercised and excluding shares to be issued under the <FONT STYLE="white-space:nowrap">Pre-IPO</FONT> ESOP, <FONT
STYLE="white-space:nowrap">Post-IPO</FONT> Share Option Scheme and <FONT STYLE="white-space:nowrap">Post-IPO</FONT> Share Award Scheme (as defined in the Prospectus)). </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GENERAL </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Global Offering, the
price of the JD Health Shares may be stabilised in accordance with the Securities and Futures (Price Stabilizing) Rules (Chapter 571W of the Laws of Hong Kong). Details of any intended stabilisation and how it will be regulated under the Securities
and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) will be contained in the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Global Offering is conditional upon, amongst
others, (i)&nbsp;the Listing Committee of the Hong Kong Stock Exchange granting approval for the listing of, and permission to deal in, the JD Health Shares; (ii)&nbsp;the final offer price for the JD Health Shares in the Global Offering having been
agreed between JD Health and the Joint Representatives of the Global Offering (for themselves and on behalf of the Underwriters) on or about Tuesday, December&nbsp;1, 2020 and, in any event, no later than Monday, December&nbsp;7, 2020; (iii) the
execution and delivery of the Underwriting Agreements on or before the dates as mentioned in the Prospectus; and (iv)&nbsp;the obligations of the Underwriters under each of the respective Underwriting Agreements becoming and remaining unconditional
and not having been terminated in accordance with the terms of the respective agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Shareholders and potential investors of the Company should
be aware that there is no assurance that the Proposed <FONT STYLE="white-space:nowrap">Spin-off</FONT> and the Global Offering will take place or as to when it may take place. Shareholders and potential investors of the Company should therefore
exercise caution when dealing in or investing in the securities of the Company. Persons who are in doubt their position or any action to be taken are recommended to consult their own professional advisers. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This announcement is not intended to, and does not, constitute an offer to sell or a solicitation of an
offer to subscribe for or purchase any JD Health Shares in connection with the Global Offering or otherwise. Any such offer or solicitation is made solely through the Prospectus or other offering documents that may be issued in compliance with
applicable laws and any decision to subscribe for or purchase the JD Health Shares in connection with the Global Offering or otherwise should be made solely on the basis of the information contained in the Prospectus and such other offering
documents. No action has been or will be taken in any jurisdiction (other than in Hong Kong) that would permit a public offering of the JD Health Shares to be offered in the Global Offering in any jurisdiction where action for that purpose is
required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further announcement(s) will be made by the Company in relation to the Proposed <FONT STYLE="white-space:nowrap">Spin-off</FONT> and the Global
Offering as and when appropriate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DEFINITION </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
this announcement, unless the context otherwise requires, the following expressions shall have the following meanings: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">&#147;Hong Kong Underwriters&#148; </P></TD>
<TD>the underwriters of the Hong Kong Public Offering </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">&#147;Hong Kong Underwriting Agreement&#148; </P></TD>
<TD>the underwriting agreement in relation to the Hong Kong Public Offering entered into by, among others, JD Health, the Joint Sponsors, the Joint Representatives and the Hong Kong Underwriters on November&nbsp;25, 2020 </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">&#147;International Underwriters&#148; </P></TD>
<TD>the underwriters of the International Offering </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">&#147;International Underwriting Agreement&#148; </P></TD>
<TD>the underwriting agreement in relation to the International Offering which is expected to be entered into by, among others, JD Health, the Joint Representatives and the International Underwriters </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">&#147;Over-allotment Option&#148; </P></TD>
<TD>the option expected to be granted by JD Health to the International Underwriters, exercisable by the Stabilizing Manager of the Global Offering (on behalf of the International Underwriters) pursuant to the International Underwriting Agreement,
pursuant to which JD Health may be required to allot and issue up to an aggregate of 57,285,000 additional Shares to, among other things, cover over-allocations in the International Offering, if any </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">&#147;Prospectus&#148; </P></TD>
<TD>the prospectus issued by JD Health and dated November&nbsp;26, 2020 in connection with the Proposed <FONT STYLE="white-space:nowrap">Spin-off</FONT> </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">&#147;SFC&#148; </P></TD>
<TD>the Securities and Futures Commission of Hong Kong </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">&#147;Underwriting Agreements&#148; </P></TD>
<TD>the International Underwriting Agreement and the Hong Kong Underwriting Agreement </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">&#147;Underwriters&#148; </P></TD>
<TD>the Hong Kong Underwriters and the International Underwriters </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">By Order of the Board of Directors</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><B>JD.com, Inc.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><B>Mr.&nbsp;Richard Qiangdong Liu</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><I>Chairman of the Board of Directors<BR>and Chief Executive Officer</I></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hong Kong, November&nbsp;26, 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>As at the date of this announcement, our board of directors comprises Mr.&nbsp;Richard Qiangdong LIU as the chairman, Mr.&nbsp;Martin Chi Ping LAU as the
director, Mr.&nbsp;Ming HUANG, Mr.&nbsp;Louis&nbsp;T. HSIEH, and Mr.&nbsp;Dingbo XU as the independent directors. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g14983g38t41.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g14983g38t41.jpg
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M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
M   !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P/_P  1"  X +0# 1$  A$! Q$!_\0 Q0    8# 0$               8'
M" D* @,$!0$!  $#!0$!               ! @@#! 8'"04*$   !@$# @,&
M 04-"0     ! @,$!08' !$((1(Q$PE!42(4%1<687&!,I?PD;'!T4)2(]/5
M5Q@9H6(S)"56AR@*$0 ! @0$ P0%!0T%"0$    ! @, $00%(1(&!S$3"$%1
M(A1A<3(5"8&1(Q87H;'!T4+2,U.3TY15E?%2)%0E\&)R0S1$-448)O_:  P#
M 0 "$0,1 #\ O\:((&B"!H@C498A?$0_1UTN4RG"3[HX9&8C8=@\E9=^RBHN
M.;+/)"2DGC=C'L6;<HG7=O7CHZ39HV1(41.=0Q2E .HAHE(3)@$SP$:XV<B9
MR.9R\+(Q\S$R+=-W'RD4];2,:^:J@(I.F3YHHLU=-U _5.0YBC[!T 9L1P@)
M(,B#.-BJNYB@!A* ]V^WAMN4/$ #8P .X=?9JIEAHGVQ4QYJ>ISZTM%Y!WW'
MN->&-ZQSC:"M4Q"T.>@,./<OFO5>CWZ[>*MQ;H@[>01DYQH4JWDHMB$1 W8(
M]Q1'5NK-,B<ODG%\VAC*"KQ&7?+[D2O>E;R*]0?/$'<'?-G!9\8P\<UBU:-;
MIJKCCRS6=^X4$)!DK2C2#XRL:V:E*I]0[&Q3*F[ (/@54!S&?L_=BD]R1+)[
M7KG]V)@].BC T00-$$#1! T00-$$#1! T00-$$#1! T00-$$#1! T01@HH5,
MACFZ 4-^H@'Y #](Z4 DR$$>(PLL1(IJ*MG1#$1$Y5-Q #%,0PD,42^(#W!I
MQ;5"3C$\NFK_ ,,0!,?#^D/Y_9IX:/;"$]D8$=)[;B("([]=_9^^/NT\I[!P
M@F(;!S)P3C7E/QIRI@3+%PF:%0<A03:.F[A SK2M2=<%G),Y&.D"2DD8D:9!
M*3;(@JBZ_P"7=$,*2@"4XAJFML*20KA#VU%"PI&*OQQQ\/>-M)X7<=L=\<*!
M9+5;:SCU@^1:V*[/T7UAEW,M).I=\]<@T118,T%G;PWDMVY"-TDP "@/415M
ML($H<XLNK*SQ,.04ED_#Q'K_ #NGYM5I813ECC&"<LJ(]J9SD*.W0JA@+^7]
M4?:'Y]-(';QAP2)X\(]6/4.LX I^O<(")NXPB)O'<3&$QA#IX#OI%>S,PBD@
M8"#6([=1\-_9[MO$=6T$P.,? . [^(" ^ A_)N&B  F/O<'O_AT0LC!;L=SJ
M-/9HR-NM%>JL>X<E9(/[)-1D$R7>&247(T2=2CIJ@HY,BB<X)@83"4HCML Z
MM:JNHJ%L.USK3+2C(*<6E )XR!40)R!,N,@8]*UV6\7RH5262DJ:RK2C,4,-
M..K"9@9BEM*B$S($R)3(';&%8N],NR#IU3;96;8U9+%;O'-9GHJ>0:.#D!0J
M#I6)=NTVZQDQ[@*<2F$O4 VTVDN-OKP30OLOA/'EK2N7KRDRAUUL-]L3B&;Y
M15=$ZXDJ0'V7&2H R)2'$I) .$P)3@S[@/AJ[F(\HS$?.X/RZ68@]';  P#^
M[W[_ ,FB".&5EHN"CW4O-2+&)BF"1G#^3DW;=A'L6Y W.X>/7:J+9J@3VG.8
MI0W\=4GGV:9HOU"TML)$RI1"4@=Y)D /7%Q24E57U"*.A:<>JW%20A"5+6HG
ML2E(*E'T $P4Z_E+&EM?C%5/(5'M$H"!W(QE=MM?FGX-T^WS%Q9QLBY< @GW
MAW'[>T-PW'KJSI+Q:*YSDT553//2GE0ZA:I#B9)43AVQ[%STGJNRT_F[S:[C
M24F8)YCU,\TC,> S.(2F9D9"<S*#T4P&*!@\!#?7HQC\9:((&B"!H@@GW*93
MAX9ZY,("9!LHH4N_Q&6$.QL0-O:=0V_Z-5&Q*:NP0OX8;/C2.E'#^86!==0Q
M6CF03;%,/EJN072,J!0$1#<Y#FV /$VVJ@D)& ]_9"J(2I5"$'OVZ;"7P$HA
MX@8.FPAJL!/$<(;,B.OZ@'],?R?$&EG* &?&$\RM1*+F;'-UQ/DJ&)9:'?Z]
M(5BU0BZZJ'S\5)("BKY3I Q%VKUN(@HBNF(*)JD*8!Z::I(6DI5BDP]*U(5F
M29$1%76;KR\].I@6B7VJWSFIQ#@MFU$RO0FJ4UR2Q!64-DF-:R?2A6(XR9 0
M;,I$D)6-,=]Y9-CIG,()ZMP7&!)7B;[".(BX/*>]DY'2<1V'U0X.@^J5P2R(
M)4HWDMCVNS!5/*>5?(SA_CBTQ"^Q1,WF8>XLXH\8Y*8=A(H<# (#T#505#)X
M*$4E4[HXI/WX4RP>H3PCHS,TG:>6> HYBD45%5FV2*_.&(0 WZMZZ[EG0B/L
M ""8?=H+S0XJ'SP!ET\$GYH47BCS-H'+.R6G[*5'(\QBRHQS<R^<+/4)>E4*
MV6)ZZ!-M7\<!8VK*6N:35DFHX=R"*!&"!11(51110Q4Z*G@LY4##O_% MHMI
MFHC,3PXGUF'U'$  -]MM_?M[!'I[]4S^&*7WXK49*SAZX[#(]_947$]F=TAG
M=;,UJ#LF,Z(Z(XJZ$P[2@W";AQ+$7<D6C2IF YP Q@'<0WU%>XWK?Q->^FDI
MJGR@=7DDPR049CEQ]4HZL:3V]^'Q4Z7MK^H;S2HOZZ!A52DU]6DBH+:2Z"E+
M1"2%S! ,AV02?OYZ^'^#MI_97C[^^-6GOKJ#_P O4_L&8][[-_AQ?SNC_J%9
M^ZAO/)"L>L9RPIL30<V\?[U8JQ"65K;HUG'T:FPBZ,XTCI&+1<'=L9PJRJ16
M4LN7RS?#N<!\0#6/ZBH-Z-642+??J&J?I$.AP)Y32?& H S3+@%$2C9NU=VZ
M'=F;\]J70&I+=2W>HI%4SBUU=4Z"TM:'",JVB <[:#,8X2X&/.XTT/U?>(\)
M:*[@SCW?*Y$W&8:3LZWDJ339X[F28L"QK99)9_-&.@4C,@%$I>@B&X]=4M-6
MK>32++K%AH:IEM]04OZ)M4U 2!\1,L#V1=;K:CZ)=ZKA27/<+4MMJJRA84RR
M45=4R$H6O.H$(:D25&<X<M]_?7P_P>M7[*\??WSK)??74'_EZG]@S&J/LW^'
M'V7NC_J-9^ZCOB\\>O(K*Q2<CB.TI1RLE'IR!QQ;0B]C$[M(KTPB28$4RD;]
MP]P=?;MTTJ;UU" A7EJG _J&92]7&*%9MS\.E-"\:>]49JPRLH_U"L]H).4"
M;6))[#AZ8E-]12Z<Y*?1\4NN%M7EK);'T[)I9!;Q=:@;"=G%$A6ZC ZR,XY0
M1:E-*"<O<F(B(]!Z:VSN96[@TM%0JT2VZY4J*^?RT(61)*<L\^ F2K 1#[I>
ML/3Y?-17EG?JL9I+*U3MFB4X\\R%.%TA<BRDE7T<L%2]$5V^87+#U-TJ&XPS
MRS;R5'JV469]X.2IM6@'MGBH9\T<.D4GD(Y<N@8?,^4"Q![2J;=O4-]HVZSU
M/N@*+W+K-;K-'4B9;4AM"G$I(F1D$\H5(8F1,=/-D-G>DM>HDZ[V96U<+Q9W
M!]*W4U#J:=QU*DI4I#J4I*B,V4B<N.'$IQPDJ/J$8Y2D<X</,-VB98W",=5!
M2[-*?7)UDY81TFDYD(^,-8'K4R';)-2%6.DGVG%("@8=AU8:)H-Q:/-?]&4C
MRN8E3)>0VVH*"2,R1F,QB!CQG/&,JZ@+UTSZJ<:V^WPOM&Q54#PJ?*JJ7V5)
M6XV4H6ODH4%#(HE 49C,20"8D'#.GKX@&P8FN?Z<88[$?W_JNMA^]^H7]15_
ML&(C1]GGPX_YU;_X^M_=QE]]?7P_PFN7[+\=_P!ZCH][]0OZBK_8,0IV]^''
M_.;?_'UO[N!]]/7P]F)[E^R_'G\<F&CWOU"?J*O]@Q#1M[\.0_\ NJ#^.K?W
M<*!]Z?7 ^U/U#[7V[[@_<7Y+Y/[;T'SOP5^&//\ FOE/J?RWE_7O@\SN[]_A
MVVZZO/>V_ON^?(JO-\[]2S/)E^:6;Y8QOZA_#_\ KGY;WO0_5KW5FS>>J\OF
MO,2RYN7FGR<<LI2QG.)TK^\=RCPT8@FJ<WS)CJ(E3,<QS$ "(I=A=S")2]>F
MI9"13D[(Y4#O[)0;\;5)Q"(K2#]'Y=PY3!%!N;;S"(F$JASJ@ _ HH( ';X@
M ::M0)DGA >$C'=9:;\R=1_#@4BXB)UV8"!"+#_..B(="*C[AZ#^33FW)8*Q
M$'9Z(2I<'350Y%2'3,0>TQ5 $ARC_O /AOJXD%<#!(&-!EQ$!WW'V_[/SZ3Q
M)P@"1..4RPB(=IA =^@E,)1#IL(@(;" [!XAUTPSA\A"<6W".&,F'*;(N(,6
MWXW:*8&N>/ZI9C=AC"82B,Q$O!$!,(CU]HZ3(E1\0!^2%SE(\)(^6._'G#CB
M]6I-M(4OC/@*J2+58KDDO7\/4"(=M5"B!@52>,(!!<BP#U+L;??0I+:!.2?F
MAO,</%1EZS#VF3)M'MD6;1%)!NW(!$DD4R(I$#<1$")) 5-,HB.^P  :MB9F
M<-G'4( /B&^B$BN_ZV7)O/\ @&_8+C<,97MF.&%AJ%H>3;6MN6K=*2=,Y=JB
MU7<@X:.1%1!(XE*("'0=1EWUU1J*Q7JA8LU;44S+E(M2@VK*%*#D@3WF6$=-
M^@7:3;3<C3>H:K7=EHKI44M;3H94^E1+:5MJ*DIDI.!(F9SAEN'&WK5Y\QU
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M>8^O5:R],1LIF/'4RD^=.V$<RAR3U(G0+](DD8IB4C=-2+?I*M5S$  ZI&,
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M?',IAZW;,6, S=>#Y*!BF:2!EP  45[Q+\/:(R/VKT74Z*TT*2X$&Z5#G-=
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M*S%3+(.,H,C[.^+VZP0C-OY*3N]5!PIYLK3E%%CI)*/&ZAA=1XG,7M5!1,!
M%>FE=X]OG-56M-VM#6>_4HEE$@IYK$E'I4DG,@=N*>V)K]&'46SLUK!S3.K7
MRWMS=UCG*5,II*E(DW4@"9"2/HWI S24JD<D-L^O<\_]+7[#?Y?\J??_ .9^
MR/G>1'_._:/Y+YC\5?.?6NW?\-?]"[>[N\WKV]GQ:Q'S6O\ [)OJW[NK??.?
MRT\OB\K*>:<^.7Z&7W(VI[OZ<O\ Z]^TCZS6;[-LOO:69<O>6;+Y?)ROU_\
)BYRED[9X1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g14983g40y88.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g14983g40y88.jpg
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M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
M   !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P/_P  1"  5 -T# 1$  A$! Q$!_\0 E    P # 0$             " D*
M!08'! L!  ,! 0$               (#! $% !    8" 0,$ 00" @,
M @,$!08' 0@)$A,4$146%P A(Q@*(B0E&7:Y.A$  0($ P0(!00" P
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M\-<91 16_&(PBM"01IJ+D<2BX4#L6WM;>%!T+%J7"DTM82(8A &5G++%P.8
M2KXGYRR;=XEK2VU(#%,(PO)M>5OV'R)\8_'KK9?,AHV7R:=R?:?8R4PV2M#$
M_$Z^UHS.;0EA 4KP2XMLD46@L-=TQ+6>A7 ZT(%@R,E)Q& ]<<3<:QI0JIZH
MWEV-;8N7[C5"(.L_*!F@&V6]^RM <@N]2)]?9MJQKYNBSS[2NKJ_8\0BQ;8U
MXU2MIK.V"P@FL75,[E-(G8D#8WM&T(5@%7GN1)Y!AQB;H)_!#GN:Y_[09=0@
MS;LL>RSA<<Q'$Y$B6.^*"Z.V9JG:RAF>_M6)I#KCB$PC)[Q"5J.0";6M8]Y;
M\J$L8EBI,W/#M"G1,X" F<B%" U<VCR/K3#&'MB>'!S5;.(GVW6WT7 0082-
MS/;F;O5AKA&-8H/6540?9O?.9-VN=!**AV3G$KL9A7O!R)1.9XWHG&@*N):6
M.)1XSL*GKW=-EI.<2%.,"P#.,)O/>&T@"IQ03^D6<K:LN>;A)-M@4J$'5B8,
M6KI/OA0.OU4Z_P GFNI-I['.,-5P>#VYL'N3)5$EMNV4<?7.ZAS'#8[JC%7:
M8(FDPDQ4)K0J#'7VA+Z*%IIV#%@C&HUH:4+MY^D*<++WEXJ%M9@-P'_*.?<G
MUF[@4WPB[-V=94LAU;;?UW3;6[.<^UCD\S2Q1!-6>?Q4I-+:]=)*TQZ7,1+L
MF"$X:%0 [*01QB;OJBL=TSSRX6E=Q;NN-L-MOYIK6*;9.:;.Z)WMA;3WH9=?
M[?WK8-T=IRH2X[/<;VM52-**QFLLV0RYDAL2.VDFJ!"E9&MI;R5]E2QVC*!*
M6!(B69)6X<@*P 3#+G)>A>I10!W3BYC;58LTMJI<3+?+PG#3[XLC8**\OG$'
M5+5:6]%90&U'?9X^Q(E<LWJ50S64W0BO6:4M[)[-6Z^4,;HS^:W!*<?<R@*R
M2E!8D!A!W4<!CB[58%< 5V1,QK#RUUQ#"X(B R4[XJ%5JTJ!*I7+E*=$B1)S
ME:Q8K.+3I4B5,6(Y0I4J#A *(3D$@R(8Q9P$(<9SG.,8_*8Y\3E:(W5O-R;U
M;RG6K]D_'-1;@?KPI_CA\:._$+$188&!V@[;;D9LM@7LSRGA(Y&WIE"7)Y*Q
M5EX&M$G6)RDH2C9V&Y<#BOH.$77F6>7=;:GW0A=LZDAM?'KL_#=O-0J7N*)*
MEP7$R*H859<8?7=:]2^N[B@*<F+6E7<X6NRI6^'2R*2]N4D*#UP\JEQ>2U@L
MC"H ,36.J8#G$UZV;=TM."RWB-AV5FB1/EE@HP[8LBLS*26_+-:JW?)-@Q(0
M8Y-8HT]24F'2UD2X4FCP>:BZ2EN0@)-"()><]6N.4^R,MC]WI[3 *6K/)1"J
M]E,HKUKY<KCFK0WX/CE9,<.;(@YRYQ,4$D%MQ$FF]8,T69"@!-$<:>K4!" H
ML70$PSH+$!,I5=WTAH )GIIU_6$P,.R&SBCF?M:E1[&;Z?1;2P:_RI/0PG2.
M&W/WI#H%LO=RR#%10Z-F,R";?.XP028WIL$HU:KH$I/.RF2*R)ZGZY:KJ92S
MP)BLLM^U#Z65SGEQ 0>//@YP%FOCAZDK]<P:[F\$W>#+8)$(Y3\KV LF8.I+
M$@"WNC)4L->H\\OL28'Y*C3O)I2L*HL+B3XQ*@SJ!AM]%:IFL*Y.HLN@!6ED
MYH.^%L[;[#WMR"4CLO!MM+RJFC: TBY68A4\CN>+ZLV6_1MN9*4?$3HRS^VQ
MLEL3:0UV1+ECQA $0V8Z/HU@RRW!R1!, (:RYUP$.1 Y,(<QC+#FNM E[[:H
M2,\0)!>DC%IT1ET4GT78)M!9(Q3"&RII0OL8E,8=4+Y'I R.1 %+>[,SPVGJ
M4#DW+4Y@1E'$F#+&'.,XSG\K!!"C".606E#(B(C.4D5T:J<AO)!+F^JW.VGK
M?Z@X1%J3K&L=A[ @MA9JJJ]?W=EN[82Q8I3[P%,AJ&KE24XH94[ 0WO*DLPA
M&$9?F&!CN!S7N**HV[L8ZW+T7+%MI*4.))(4*3(!<SNCCW'=7\ZV/1<&5>1Y
MWA,7F6IMBUGLM)*_L?8RT2I%.-:'%F>,L5RTI5MAK3ZO=6MQ7HUC2L;(*G\]
MF>$1J5P 2F$!09ZV"XM&#A-%.V-ON#-5V+7 A0!(["1/ORBZ>V)%'(E'FZ22
M. RFQ"F>2-*MI:89 EMBR)L?/]@IOD+>R-Z56M2#:\&#]5Q80Y2X,]>H.,YS
M^6%!B%CDM!)0%/"/GV;_ &(EI;1'(I7EX.432WOR#[)6_>%05._U!L R6NV4
MO9-BM+2.1H9<X2N(5DSO4:8R5#@%(\,:U&J7E')"UQWIG!$#TMAR\1<H$\%C
MLVEO.86+0QH!*A%3J)Z80VBL(N_,]5Z1[):N4>*YI[KPXUU'#7.O] Y[+[3=
M(NT-)=:79!P6A<6V$>CE=+&H*=8<] 92T2]8[-A"<M+@@0R!.:"C7-RW?6)G
MN%3V7"@=_()N* 3@Z^?]W&HHSC@?TR)>D-.Y7-'GI,VNC<K+<TYHETP7D(7%
MG*SA>!>4/."SDH,X.[F,EA_S]/P[_"T_S$*Y+C>/^MT2Y7E1=I5XHO"\Y"S,
M%;67IK;]\;OW958#[VF5@*%NU9(QQTXU+*M>8#!*TB9: 05+6L6.3NB6"2C2
M*3P'X-$&8M=,G$%<\^R.@U[" W%K@&@R3T]L'IQ/1B6UYR!\+E63*"2Z$+J[
MTCWU2,*B61MRC0I_!IK8;]:$*LQJ2.+@Z^J28,<X+..*)/&G2*P&D%_M@ (;
M+*AS0=A\X3S)#K-UP(*N;V8!(9KR.1>SI=S/4VYT^&'&O]0\26W<UF)TY*D1
ML?:HC,Y:= $XQCC!A;@0].2I4>%#UY[0Q)S.K'Z8SAEQ=1!C23$]BD<J:U0W
M /.!,T.M&(:-\4?']N%,K5GU15=9.K,RKFS)E#XI3CXX$SVLU5B3N@X@NDU@
MU1/Y*U1>P"VZ3,J1M K+9\2AR0=HDE2O4&*!:0Q@>20$/2<-NM-[F'V@ 7!P
M(QP* X$82/5#+N '4N65[I]#-G]DJ\J]#L]L6JEEK)7A%K_3U96=75662\#?
M(U7[M*X%!XJ_NJ9Y:P)W<Q*LSC"$*PM$$ "TH !.PQ&5.2H[H1SMT.NFW;)T
MVRQ)!(SA=.T&G;LJ_L#ZN,SC;+\EMK<'5+;]UM*UVDHSS8/#_8GF ,4*I1M5
MJ<IH2=!*: <S,[KG!JG#TM4O:@LT\WQL ZW]X3F05^D.MW1[)Q3TM<U!XSVJ
M?E'HEUD7I6:[G J.@MCK5J72?B[U)BL+UMA]<)JLCY4%N5?2+C+5L-0S)/6H
MI8X-$'-2%) %C</=21'%F'+1JAY/SAJ%8!(8T2[H\UK':3WM!NW'3QP7KSAL
MO"KJW6>LO'74%O5Y5;>?>.S=-0#8:[G)E3LC#(+1LV:0=ND@4!9RPYIC<=:P
M&N'91(RLHFM((XP[H (TX8FV6AML$"9"F)N;N.N7RUQ]#20-P$)7Y!J6MMAY
MC.+6YMGY]$9;9%[@VC2#JPVI95L/KQ0=:U]7)(H/6,0J=B*8YY;[N:JERU?(
MY /"$QR>S2E9:-$@;R4X4W&D76N>9E<E BNR]IY6XRV"&A)JA)7%<MPV1F=T
M(E!#^2+@]1)H[2QB4_<^2J%::O\ 0VS=0>Z<UQB/.C6<\+;*=G9//@H'-(4>
ME(28 8W'E]X><X,#Z:X#4;ACL39&6B="\9\&;@[X0Z/^P1C&>&C?[&<].,TP
M1C(O3.?3&9S$/7/IC]<^GX^]^,],XEY+^TSK\HC[VGE=T2R$76V8I*T:BUJS
M*^%=IEHI>$A'$Y=M4P-4.8W*Q*L?8ZO/9E9]BTDM:U#DH;C_ #L@0H#E^$ZO
MM@Q(5(,B&R[TCI6PT.!J!N>ON7/M^D.*L>M[ZM?D0B-<:MQU<\<@?&]<5L2A
M/8>XFU$F?*)QJCL6Y!>:XES55[RXSZYK*=G2H74N(*U<>*:FJ/N:0Q0O,5KA
M( %,(<;B-XVDXF2'QPB9KF-L%US\%P"31-1C.0$YSBCO;"C+7VFJ=KU\S+DU
M35W:2 +3L_+8,^.1D[4UZ8E2AEU15$YF-;88TF6?@]0TK9.I 0J;&+*C*5'Y
MRD@Y%0YI<*<!G$-M[;;JT5PPZ]IZMD).BD0FUV\BZFVM645MP7CEX>:@6ZZ0
M*L-:'XR)MVU5[-"I"Y6I4L,9#7-HC5@PFIFYI1M+DF4FB+<9&TA0%*,&G*32
MDH2]6KIM"2S/TBLEK+%%Q#?NE5.0R/;'9M8M,6RQMPL\G_&1O2*NM2-LDZB<
M[,Z^((,":1&S[F:5Z1M=5N8M)5S.*JIBOR%<"2]Y,FD;.]DF #C)2L\@C6L5
M^K;<C#B(&Y=+;7M^88MUN!V#SW91V[^P_*91".'C<67PF2/L.E\;:*H>(Y*8
MP]+X[(&%W17K6)J-S:7QL4HU[8L3&XQD)I1H!8QZ_KZ9S^%?E:)ZOB(7R0!Y
MI@,P5^!A2NRD_;W?9'^OL3!;5W5+?K!V5B*RV#K/F.WL>9I68IJ>/*W++*KM
MHQJC+\C<U+FM*7 9A'DGMBPTLW'B'_Y+)4L2I>W=%+ C+U09PR2G?LCVQK_Z
MH[J_\UU@_P#6KMW^"/[9[/\ 4QA_\X=O^[88(\DZGE;4;%DSYQVF7\JP8.,-
M=N29EA+1?)U'9PK^/G<?C(\O[W0Z:F *,J</1>' UQ$KPKS,1A%D> M]-15=
M7Q[,NDX5]W3;33[;/8O\LUZ"!.X($-5H=/N58.WTHG$HD1VT]\G<@9^Q4$KF
M!L3<]_ $!=F-ZM+7UC6.PO*+V(M2<\+"CD!'GFFDHDWCE$GG+L)0ZO:56&<Y
M5J6]( "D4H2<Y8@0>W!^EI4'$O72;2M[V*4U9EUOOZL>;]BT'16L$T=K38P/
MLL9#,'"NQ,25<(13)W7;",\L 35O9-&I) RS3I>A4GC"><K]R=6FJ2IAA&L-
MH=,1:P\G8:K-EI.YPM:KS#MP?L>G\C<DI3FII=B,&V E<%*5.?5@$O;S&"X>
M<770DV X9AA#D8L>]%+DXT*KCTZI1OW=2W5^*H(G#C\=JSVPF*>I^)@K@<XO
M4^]+M:B^T<4HVAU)=M>8\SM&[8G@;HKRXFU='D<G>V<#$F&).%<6\N@F0\P!
M(LC*7C("!3]+2%:KDF,56_=>[?HHB^I>'IXQ475B4M7HW!"=,7RW8\U?7[<.
M%N-JQ60S&_\ P"VW(E:8UFVAF,&)^U%:O'06?*U_LB=7D0S"3DV EBH'!Z%\
M_&.>[\QU4QRP\,NJ)2^1U/QG*N.'?1/%WBWF3?PR:4&';5XW&C:64\AJ1K^]
M:^Z#D\<E$KA\6<*YR3@GP2J\=4L%PWY+[!F2\%^LUW3TG8UK-<<NDHZ-C7]P
MQ4T4*4\.!Z3G!$["MU**N0*,#X_)CRK,5VH#Z</Y!T_'-6T6EFNLK/ RQG"Q
MKNI7.+6AE?U_?RF(8(RZKVTB3&D%BQA0C.<PBR(G4U^BI<TZ8]-L!;JT3K"W
M1^VHE<\)3'=W0PSGO2-BS7KCK*<I!94;*#R6Z>&LZUAA\0FMD'RDM%-,Q1 K
M:[#G, BJ5Z5O';"I5N*PY*G4>HCTQY?6'\/F.%N/$(1R?Y'X?C=U>"P*/)JE
MTFQ$MC?^P)\O83U]9Z_?>V"HKQJ OC-4_:\F^C?;11.9#L##/B=>_=/LN,K/
M;_-\G_5Z/P;M-)U%3L@^7U*QH4K-.+9TQSC9H&W,7_=YQFK'.87CD)&@]\ H
M>.RRM]7\0QTJ8QF+"UGH)G0MJY+88XD9!$#0$G,+DM4& )!W"2!F&%D/RMQP
ME@F>R/.J]J_A2L+BJRVP2&ZJ5*=,.3TJM7W8EMW?5Z_U#[ NI:*4\].3#JY\
M/L\FO?C[7<,S8(S+:Q^SBYJHFO=6,CK[F<6G1?J2VJC_ #\7(NHF6SHL!95+
M=5.C4<5QDN$U1$A5%<(-3T_$OQ^&[\2K8QXXI@5:ZH(>@@\ 1QN(JK'2N$Q^
M(2O<MVKVRI5:J![>Y0)7\#C[ B4PQJ>0H?>7EP6B1]"_3I#4733QW^644NU/
M<OT WW*[<OXJ$ZR9[!#*>"IJVT0MTJ/FLZY(Y1I\I)2#U;;-YJHUC@3XRUZ)
MH+&T)I$^-USV/LA)E16# %-)^&YH8S$!11N2@=W))++%>=5&2I^L3\X;7[1;
M%W.DDS[@(QV]264'<^F@IE7/J%NN_P#@9M>FJ=%*8GAZKSWE6-]3N;W,G-),
MV%[P6P-1HU:)K3).AW6$%I#W!M)/&M3Z]=4)Q)+QCUK^F^K\=87;EAT^"%46
MX;8PJ.)"S46IDWWF9XX5<MZ%<QDEDE6ZWR2S%\W#+2BMC5VP4'D=PQ58TW*8
M\^TGQA+ Y"M8@0_MD'J!I>A1^)?^+T+CZL/'?%-K^R-0,P%$W)N26'6,<(LK
MU0Q @ZM:UAJHQU-K -!4[BN#7XE(G?#('BNX[B(&/1#>>I0$.PX_X^5("3#"
M@G9%@ A!QC.:V)2$P2.7=JU'5<517K6$S<BB=L.YP.#$U8\.S<XIR=US&-$V
M1M"\IG=1FJV(+DE>71;*F(R.H ->3!A4$(W0T9@>CLAP+N!5<_,SMBJQ_4O?
MX_& 9W.03T[G.XP%5PRK<=NUI)OJ4#UV8K+@%&O47<MB@,*H,F30:5M]EL-N
MLM/J68UH&I.DS,X+B#"#0-A1J<_N)P=5K-6JCL_6'VJ?9W*0S4IFA.'<BXX0
MWCG\+1F\.>^I;BJ4(4 Z>1X6JT;>6ZJR$OSR']\:9O.<F<I6?@KUZ "5$AZO
M3U%Z?CKOXSTSB3DU]RQ,5\H6+S.((*HX7N.PBR)9L8TU2FGNB0Y:ZT!7M9R&
MRWE"36I8&=.7'Y=9L8!&90XN&2S&<YI<W;".082EFE*DV<F83=_"U526$4\J
MONKE(;4CL24QZHX3R-H^,E:KXS2]8I%O3&MTBS,J*-6:-0TR<;IK*E(DB@=N
M-&PS;<<\KV1-LA<Y;AU*5.,F5JG9#(<N)JM$K18<"LC<TO3357DF/:L'R_N/
MN:E&EG5PKDB ^&4/?Y(DERKN,N9)*@D&[,6MPZ(UB%M?]?X?!Y]MRVAP]QH<
MM-=(@CG%;0U[>C(R%>6_EMCXW]&1FF(!B- 26-]RK3]*U;L8CL4>X%=!:IQD
MWX'LE"(="$$@05'4I0Y5_8PEE XB;3];N%?P#5VOJ7%%>L?9RD:-4K*LVV0#
MRJ[OF8&N$YX5=WRLY4=W\0S )J4IEAX3BN]Q&5@/6:DD^( @R?Z]J2F"+HY=
M#]:G_81TH!5MXQ"BC9<$17L$89)D"/OWV83''R1S:2364SE1)AYQ(#'=N9W$
ME$4TY5 -4&F8)/EZ5=0J+G"N=KIMZE-=.6R2+Y)^KN]X/XB_Q?L[^=OP+^*G
M;BOVM]G^7\$\;YM&_B_R/POWO"^:^V^GK^UW.GN_M=?X]U*>K"([==?V^*?P
MGX1OTN^IOKV/^%XOMWPY7]2_6G@_-O9?C)?:^E/:O^1\WXSV^Q[7_CXO3U?L
M^OYXHG3PCS:E^*^<0@QQHO/')W<J@-A<AYF\IFZ&M!Y[0.G-02;W2:<DZV[9
M"2-:>1AO4^HG&U''78\X!R\;6EPC1I2Q@1JG-48!'"%U3Q:BC8J(=^R.P2S0
..$K>C2<W)4K=RHO1(_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
